MarketWise raises full-year billings guidance by 10% following stronger-than-expected second-quarter performance.
MarketWise shares climbed 6.4% in after-hours trading after reporting a 56% year-over-year increase in second-quarter billings, reaching approximately $91 million. The company also raised its full-year billings outlook by 10%, citing robust demand.
The quarter marked the highest billings in the company’s history, surpassing prior expectations. Analysts had anticipated a solid quarter but not the scale of the beat or the upward revision to guidance.
The stock’s gain reflects investor confidence in the company’s growth trajectory amid improved market conditions.